Related Experiment Video
Updated: Jun 19, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Update on antiretroviral therapy in paediatrics
Martina Penazzato1, Daniele Donà, Pia-Sophie Wool
1Department of Paediatrics, University of Padua, Via Giustiniani 3, 35128 Padova, Italy.
Insights
Pediatric HIV management has advanced, but new infections persist, especially in developing nations. Optimizing treatment, preventing opportunistic infections, and addressing psychosocial needs are crucial for children living with HIV.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Significant progress in diagnosing and treating pediatric HIV infection has been achieved.
- Despite advances, new pediatric HIV infections remain a global concern, with over 1150 daily cases, predominantly in developing countries.
- Mother-to-child transmission (MTCT) is the primary route of infection in children.
Purpose of the Study:
- To review current management strategies for HIV infection in infants and children.
- To highlight ongoing challenges and necessary efforts in optimizing treatment and care for pediatric HIV.
- To emphasize the importance of preventing opportunistic infections and addressing long-term psychosocial consequences.
Main Methods:
- This is a review article, synthesizing current knowledge and research on pediatric HIV management.
- It draws upon data and recommendations from global health organizations (e.g., WHO).
- The review focuses on antiretroviral therapy, opportunistic infection prevention, and psychosocial support.
Main Results:
- Comprehensive strategies have reduced MTCT in Western countries, but further reductions are needed globally.
- Prompt initiation of potent and tolerable first-line antiretroviral therapy is central to effective management.
- Opportunistic infections, adherence, and psychosocial factors are increasingly critical considerations.
Conclusions:
- Continued efforts are required to further reduce MTCT and optimize care for HIV-infected children.
- Personalized interventions and new strategies are necessary to improve outcomes.
- Effective management necessitates a holistic approach, including timely treatment, infection prevention, and psychosocial support.
Abstract:
This review provides an update on the most relevant issues concerning the current management of HIV infection in infants and children. Tremendous progress has been made over the last few years to diagnose and treat infants and children with HIV infection, yet much remains to be done. Every day there are nearly 1150 new infections in children under 15 years of age, more than 90% of them occurring in the developing world and most being the result of transmission from mother-to-child (WHO 2008). The comprehensive approach to preventing mother-to-child transmission (MTCT) has clearly reduced the number of children acquiring the infection in Western countries; while a further reduction of mother-to-child transmission should be aimed for personalized setting, specific intervention needs to be put in place and new efforts are now required in order to optimise treatment and care in HIV-infected children. The prompt initiation of treatment and a careful selection of first-line regimen, which considers potency as well as tolerability remain central. In addition, occurrence and prevention of opportunistic infections, adherence as well as long-term psychosocial consequences are becoming more and more relevant in the era of effective antiretroviral therapy. This article forms part of a special issue of Antiviral Research marking the 25th anniversary of Antiretroviral Drug Discovery and Development, vol. 85, issue 1, 2010.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Retroviruses

